SIGA Technologies Inc. (SIGA) Fair Value 2026

SIGA · Pharmaceutical Preparations ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

10.0 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (18/100)

Quick Summary — As of 2026-07-13, SIGA Technologies Inc. (SIGA) trades at $3.61, approximately 65% below CirclFi’s Bayesian DCF fair value of $10.44. QOC: 10.0/10. Value Trap Risk: 18/100 (SAFE). 12/13 models active.

Key Facts

Ticker
SIGA
Price
$3.61
Quality Score
10.0/10
Value Trap Risk
18/100
Models Active
12/13
Last Updated
Strength: Bayesian DCF suggests +189.1% upside with 62% confidence
Risk: Limited model coverage (12/13) may reduce confidence

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($3.61)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$10.44 +189.1%
Earnings Power Value
High Conviction
$8.57 +137.5%
CUCE Ensemble
Low Conviction
$7.98 +121.2%
First Chicago
High Conviction
$8.12 +125.0%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is SIGA Technologies Inc. (SIGA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, SIGA Technologies Inc.'s intrinsic value is estimated at a composite fair value of $6.73. At a current market price of $3.61, 11 of 12 active valuation models identify upside potential, projecting an average implied return of +86.5%. Notably, RCMH-DCF sees the most upside at +232.5% (fair value: $12.00), while Dynamic NAV is the most conservative at -53.1% ($1.69). The spread between these extremes — +285.7% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About SIGA?

12 of 13 models are currently active for SIGA. Of these, 11 models suggest upside while 1 model suggests overvaluation. The Bayesian DCF estimates SIGA's intrinsic value at $10.44, implying +189.1% upside from the current price. See which stocks rank higher →

How Does SIGA Rank in Pharmaceutical Preparations?

Among 440 Pharmaceutical Preparations stocks, SIGA ranks #5 by Quality of Company score. CirclFi's QOC score of 10.0/10 evaluates 32 fundamental signals. A score of 10.0 places SIGA in the top tier.

See all Most Undervalued Pharmaceutical Preparations Stocks →

SIGA Technologies Inc.'s positioning within the Pharmaceutical Preparations segment means that R&D productivity ratio plays an outsized role in fundamental analysis. The sector's unique characteristics — including licensing and M&A optionality — shape both the opportunity set and risk profile.

Is SIGA a Value Trap?

CirclFi's Value Trap algorithm assigns SIGA a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for SIGA Technologies Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, SIGA Technologies Inc. earns a quality score of 10.0/10. This exceptional rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +285.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SIGA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SIGA's 12 active models, average confidence is 45%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy SIGA Technologies Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Pharmaceutical Preparations Stocks Should You Also Analyze?

8 related Pharmaceutical Preparations stocks with 13-model coverage

Read investment analysis: AZN · CPRX · HRMY · NVO · UTHR

See all Pharmaceutical Preparations stocks ranked →

Frequently Asked Questions About SIGA Technologies Inc.

What is SIGA Technologies Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, SIGA Technologies Inc. (SIGA) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $10.44. The Quality of Company score is 10.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SIGA overvalued or undervalued right now?

At $3.61, 11 of 12 active models suggest SIGA may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits SIGA Technologies Inc.'s business model in Pharmaceutical Preparations.

What does a Quality of Company score of 10.0 mean for SIGA?

SIGA Technologies Inc.'s QOC of 10.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on SIGA?

CirclFi analyzes SIGA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is SIGA a value trap in 2026?

SIGA Technologies Inc.'s Value Trap score is 18/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on SIGA.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access